Teladoc Health Inc (4LL.F)

Healthcare | Medical Healthcare Information Services
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 626,439,000 631,900,000 629,369,000 640,491,000
Cost of Revenue 187,179,000 190,537,000 196,829,000 188,928,000
Gross Profit 439,260,000 441,363,000 432,540,000 451,563,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 221,873,000 325,612,000 329,652,000 274,722,000
Operating Expenses 491,222,000 495,748,000 553,151,000 499,778,000
Operating Income -51,962,000 -54,385,000 -120,611,000 -48,215,000
Interest Expense 4,526,000 4,473,000 5,765,000 6,846,000
Income Before Tax -50,222,000 -40,423,000 -111,267,000 -48,171,000
Income Tax Expense -715,000 -7,763,000 -18,255,000 238,000
Net Income -49,507,000 -32,660,000 -93,012,000 -48,409,000
Per Share
EPS -0.28 -0.19 -0.53 -0.28
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 2,569,574,000 2,602,415,000 2,406,840,000
Cost of Revenue 751,270,000 760,031,000 743,987,000
Gross Profit 1,818,304,000 1,842,384,000 1,662,853,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 1,346,270,000 1,367,293,000 1,300,563,000
Operating Expenses 2,839,190,000 2,090,937,000 1,890,219,000
Operating Income -1,020,886,000 -248,553,000 -13,653,214,000
Interest Expense 23,803,000 22,282,000 9,270,000
Income Before Tax -993,653,000 -219,608,000 -13,663,343,000
Income Tax Expense 7,592,000 760,000 -3,812,000
Net Income -1,001,245,000 -220,368,000 -13,659,531,000
Per Share
EPS -5.87 -1.36 -84.60
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 1,298,327,000 1,123,675,000 918,182,000
Short Term Investments 0 0 0
Net Receivables 223,955,000 230,063,000 210,554,000
Inventory 38,138,000 29,513,000 56,342,000
Total Current Assets 1,663,907,000 1,489,048,000 1,315,388,000
Property Plant Equipment 56,579,000 72,092,000 71,472,000
Goodwill and Intangibles 1,714,550,000 2,750,971,000 2,909,955,000
Total Assets 3,516,524,000 4,392,369,000 4,345,355,000
Liabilities
Account Payables 33,130,000 43,637,000 47,690,000
Short Term Debt 561,060,000 10,752,000 13,592,000
Total Current Liabilities 941,535,000 420,616,000 399,769,000
Long Term Debt 1,023,553,000 1,581,525,000 1,573,330,000
Total Liabilities 2,025,445,000 2,066,296,000 2,037,610,000
Shareholders Equity
Retained Earnings -16,229,900,000 -15,228,655,000 -15,008,287,000
Total Shareholders Equity 1,491,079,000 2,326,073,000 2,307,745,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 1,298,327,000 1,123,675,000 918,182,000
Short Term Investments 0 0 0
Net Receivables 223,955,000 230,063,000 210,554,000
Inventory 38,138,000 29,513,000 56,342,000
Total Current Assets 1,663,907,000 1,489,048,000 1,315,388,000
Property Plant Equipment 56,579,000 72,092,000 71,472,000
Goodwill and Intangibles 1,714,550,000 2,750,971,000 2,909,955,000
Total Assets 3,516,524,000 4,392,369,000 4,345,355,000
Liabilities
Account Payables 33,130,000 43,637,000 47,690,000
Short Term Debt 561,060,000 10,752,000 13,592,000
Total Current Liabilities 941,535,000 420,616,000 399,769,000
Long Term Debt 1,023,553,000 1,581,525,000 1,573,330,000
Total Liabilities 2,025,445,000 2,066,296,000 2,037,610,000
Shareholders Equity
Retained Earnings -16,229,900,000 -15,228,655,000 -15,008,287,000
Total Shareholders Equity 1,491,079,000 2,326,073,000 2,307,745,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -1,001,245,000 -220,368,000 -13,659,531,000
Depreciation & Amortization 382,843,000 351,323,000 270,643,000
Stock Based Compensation 145,951,000 201,550,000 217,852,000
Change in Working Capital -36,315,000 11,643,000 -60,971,000
Operating Cash Flow 293,680,000 350,021,000 189,292,000
Investing Activities
Capital Expenditure -10,790,000 -156,348,000 -172,764,000
Investments -10,790,000 -156,348,000 -172,764,000
Investing Cash Flow -124,052,000 -156,347,000 -167,743,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 8,314,000 10,854,000 0
Dividends Paid 0 0 0
Financing Cash Flow 8,312,000 10,854,000 6,497,000
Summary
Free Cash Flow 282,890,000 193,673,000 16,528,000
Net Change in Cash 174,652,000 205,493,000 24,702,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -1,001,245,000 -220,368,000 -13,659,531,000
Depreciation & Amortization 382,843,000 351,323,000 270,643,000
Stock Based Compensation 145,951,000 201,550,000 217,852,000
Change in Working Capital -36,315,000 11,643,000 -60,971,000
Operating Cash Flow 293,680,000 350,021,000 189,292,000
Investing Activities
Capital Expenditure -10,790,000 -156,348,000 -172,764,000
Investments -10,790,000 -156,348,000 -172,764,000
Investing Cash Flow -124,052,000 -156,347,000 -167,743,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 8,314,000 10,854,000 0
Dividends Paid 0 0 0
Financing Cash Flow 8,312,000 10,854,000 6,497,000
Summary
Free Cash Flow 282,890,000 193,673,000 16,528,000
Net Change in Cash 174,652,000 205,493,000 24,702,000